SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $229,531,000 | +66.6% | 1,443,145 | +0.3% | 0.28% | +44.7% |
| Q4 2018 | $137,786,000 | -38.4% | 1,438,424 | -9.2% | 0.20% | -24.2% |
| Q3 2018 | $223,687,000 | -10.6% | 1,583,620 | -0.9% | 0.26% | -13.0% |
| Q2 2018 | $250,162,000 | -0.7% | 1,598,167 | +2.2% | 0.30% | -4.8% |
| Q1 2018 | $251,876,000 | +3.4% | 1,563,778 | +5.7% | 0.31% | +6.8% |
| Q4 2017 | $243,693,000 | +118.0% | 1,479,531 | -17.5% | 0.29% | +114.6% |
| Q3 2017 | $111,766,000 | -21.4% | 1,794,004 | +0.5% | 0.14% | -22.2% |
| Q2 2017 | $142,209,000 | +12.5% | 1,785,640 | +0.4% | 0.18% | +15.0% |
| Q1 2017 | $126,450,000 | +27.9% | 1,779,239 | -8.1% | 0.15% | +22.4% |
| Q4 2016 | $98,856,000 | +12.0% | 1,936,075 | +1.1% | 0.12% | +12.6% |
| Q3 2016 | $88,226,000 | +280.2% | 1,915,874 | +148.8% | 0.11% | +270.0% |
| Q2 2016 | $23,205,000 | -3.4% | 770,157 | +2.7% | 0.03% | -6.2% |
| Q1 2016 | $24,031,000 | – | 749,566 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |